Research News | Feb. 07, 2018

Atacicept Study Data Shows Promising Results

Results from a Phase IIb 24-week clinical trial show that Atacicect is safe and may benefit people with high levels of disease activity.

General News | Jan. 12, 2018

New Year Rings In New Hope for People Affected by Lupus

There has been significant progress, not only in awareness, but also in lupus research and advocacy efforts to secure additional research funding for lupus.

Research News | Jul. 21, 2017

FDA Approves BENLYSTA as a Weekly Self-Administered Injection to Treat Lupus

Benlysta SC is the first self-injection lupus treatment that can administered at home once per week.

Research News | Nov. 15, 2016

LFA-Funded Study Helps Expedite Drug Development

This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.

Research News | Aug. 15, 2016

Phase IIB Clinical Trial of Voclosporin Successfully Achieves Primary Endpoint

Trial results offer hope of a more effective and tolerable treatment option to manage lupus-related kidney disease.

General News | Jul. 08, 2016

New Grant to Increase Minority Participation in Lupus Clinical Trials

The year-long initiative to make research on lupus treatments more inclusive and effective formally began on July 1.

General News | Jun. 16, 2016

$5 Million for Lupus Research Passes Second Critical Hurdle

The provision was approved by the U.S. House of Representatives' Appropriations Committee.

General News | Jun. 01, 2016

Lupus Groups to Host Patient-Focused Drug Development Meeting

Lupus organizations announce groundbreaking collaborative initiative to inform lupus drug development.